Rao AV - Search Results

1

Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability.

Lee DM, Sun A, Patil SS, Liu L, Rao AV, Trent PT, Ali AA, Liu C, Rausch JL, Presutti LD, Kaczorowski A, Schneider F, Amankulor NM, Shuda M, Duensing A. Lee DM, et al. Among authors: rao av. Sci Rep. 2022 May 18;12(1):8275. doi: 10.1038/s41598-022-12000-2. Sci Rep. 2022. PMID: 35585158 Free PMC article.

2

Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era.

Zhang X, Deibert CP, Kim WJ, Jaman E, Rao AV, Lotze MT, Amankulor NM. Zhang X, et al. Among authors: rao av. Cancer Gene Ther. 2021 Sep;28(9):971-983. doi: 10.1038/s41417-020-0205-8. Epub 2020 Aug 5. Cancer Gene Ther. 2021. PMID: 32759988 Review.

3

In vivo efficacy of decitabine as a natural killer cell-mediated immunotherapy against isocitrate dehydrogenase mutant gliomas.

Zhang X, Kim WJ, Rao AV, Jaman E, Deibert CP, Sandlesh P, Krueger K, Allen JC, Amankulor NM. Zhang X, et al. Among authors: rao av. Neurosurg Focus. 2022 Feb;52(2):E3. doi: 10.3171/2021.11.FOCUS21489. Neurosurg Focus. 2022. PMID: 35104792

4

Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles.

Ludwig N, Rao A, Sandlesh P, Yerneni SS, Swain AD, Bullock KM, Hansen KM, Zhang X, Jaman E, Allen J, Krueger K, Hong CS, Banks WA, Whiteside TL, Amankulor NM. Ludwig N, et al. Neuro Oncol. 2022 Feb 1;24(2):197-209. doi: 10.1093/neuonc/noab153. Neuro Oncol. 2022. PMID: 34254643 Free PMC article.

5

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo.

Murdock MH, Hussey GS, Chang JT, Hill RC, Nascari DG, Rao AV, Hansen KC, Foley LM, Hitchens TK, Amankulor NM, Badylak SF. Murdock MH, et al. Among authors: rao av. Oncotarget. 2022 Feb 21;13:426-438. doi: 10.18632/oncotarget.28203. eCollection 2022. Oncotarget. 2022. PMID: 35198102 Free PMC article.

6

Mutant IDH1 regulates the tumor-associated immune system in gliomas.

Amankulor NM, Kim Y, Arora S, Kargl J, Szulzewsky F, Hanke M, Margineantu DH, Rao A, Bolouri H, Delrow J, Hockenbery D, Houghton AM, Holland EC. Amankulor NM, et al. Genes Dev. 2017 Apr 15;31(8):774-786. doi: 10.1101/gad.294991.116. Epub 2017 May 2. Genes Dev. 2017. PMID: 28465358 Free PMC article.

7

Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.

Guan X, Luo L, Begum G, Kohanbash G, Song Q, Rao A, Amankulor N, Sun B, Sun D, Jia W. Guan X, et al. J Exp Clin Cancer Res. 2018 Oct 17;37(1):255. doi: 10.1186/s13046-018-0923-z. J Exp Clin Cancer Res. 2018. PMID: 30333031 Free PMC article.

8

Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model.

Bose A, Lowe DB, Rao A, Storkus WJ. Bose A, et al. Melanoma Res. 2012 Jun;22(3):236-43. doi: 10.1097/CMR.0b013e3283538293. Melanoma Res. 2012. PMID: 22504156 Free PMC article.

9

Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cells.

Rao A, Taylor JL, Chi-Sabins N, Kawabe M, Gooding WE, Storkus WJ. Rao A, et al. Cancer Res. 2012 Jul 1;72(13):3196-206. doi: 10.1158/0008-5472.CAN-12-0538. Epub 2012 May 2. Cancer Res. 2012. PMID: 22552283 Free PMC article.

10

Adenosine receptors regulate exosome production.

Ludwig N, Azambuja JH, Rao A, Gillespie DG, Jackson EK, Whiteside TL. Ludwig N, et al. Purinergic Signal. 2020 Jun;16(2):231-240. doi: 10.1007/s11302-020-09700-7. Epub 2020 May 22. Purinergic Signal. 2020. PMID: 32440820 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page